Ángel Guerrero Zotano

Author

Also Known As

A Guerrero Zotano, Angel Guerrero Zotano, Angel Guerrero- Zotano, Ángel Guerrero Zotano

Publications

695

Citations

H-Index

Concepts

All Affiliations

ÁG

Ángel Guerrero Zotano is an author at Fundación Instituto Valenciano de Oncología specializing in oncology, clinical trials, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	551
2	Medicine	1	1	551
3	Cancer Therapeutics	1	1	551
4	Clinical Trials	1	1	551
5	Breast Cancer	1	1	551

Ángel Guerrero Zotano

Publications

643

Citations

H-Index

Page 1

	Year	Citations
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan, Suzette Delaloge, Frankie A. Holmes, The Lancet Oncology Breast OncologyHealth SciencesMedicineClinical TrialsImmune Checkpoint Inhibitor	2016	551
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study Eduardo Martínez de Dueñas, Ana Lluch Hernández, Ángel Guerrero Zotano, Breast Cancer Research and Treatment	2014	65
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial Frankie A. Holmes, Beverly Moy, Suzette Delaloge, European Journal of Cancer	2023	27

Page 1